(2021). Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report. Reactions Weekly.
Chicago Style Citation"Dexamethasone/remdesivir/tocilizumab: Lack of Efficacy and Off Label Use: Case Report." Reactions Weekly 2021.
Cita MLA"Dexamethasone/remdesivir/tocilizumab: Lack of Efficacy and Off Label Use: Case Report." Reactions Weekly 2021.
Atenció: Aquestes cites poden no estar 100% correctes.